Disturbed immunoregulatory properties of the neuropeptide substance P on lymphocyte proliferation in HIV infection
Open Access
- 28 June 1994
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 96 (3) , 384-388
- https://doi.org/10.1111/j.1365-2249.1994.tb06039.x
Abstract
The neuropeptide substance P (SP) is known to increase cell-mediated immune responses in animal models and healthy subjects. Several studies have suggested an involvement of neuropeptides in the immunopathogenesis of some diseases. The study of the immunomodulatory effects of neuropeptides, namely SP. may represent a model for the analysis of Immunoregulatory defects in HIV infection at the level of the interaction between the immune and nervous systems, both of which are known to be affected by the virus. In the present study, we investigate the possibility of a disturbance in the immunomodulatory properties of SP in HIV infection by analysing the effects of SP (10−10 10−6) on the lymphocyte proliferative responses to concanavalin A (Con A) and phytohaemagglutinin (PHA) assessed by3H-thymidine incorporation in peripheral blood lymphocytes from 34 HIV-infected patients (16 asymptomtic (ASY) persistent generalized lymphadenopathy (PGL); 18 ARC/AIDS) and in 37 healthy subjects. In ASY/ PGL HIV-infected patients, SP 10−7M was identified as the concentration inducing the maximal increase in the lymphocyte responses to Con A and PHA, similarly to what was observed in healthy subjects. In ARC/AIDS patients, SP appeared to inhibit the mitogenic responses, particularly those induced by Con A. in contrast to the effects found either in healthy subjects or in ASY/PGL patients. These results suggest the existence of an alteration in the in vitro immunomodulatory properties of SP in ARC/AIDS patients compared with healthy subjects and ASY/PGL patients. In conclusion, the unexpected finding of an inhibitory effect of SP on lymphocyte proliferation from ARC/AIDS patients justifies further investigation of the neuropeptide-dependent immunoregulatory systems in HIV infection.Keywords
This publication has 34 references indexed in Scilit:
- Substance P induces a rise in intracellular calcium concentration in human T lymphocytes in vitro: evidence of a receptor-independent mechanismJournal of Neuroimmunology, 1993
- Evidence for prostaglandin-producing suppressor cells in drug-induced liver injury and implications in the diagnosis of drug sensitizationClinical and Experimental Immunology, 1992
- Differential processing of substance P and neurokinin A by plasma dipeptidyl(amino)peptidase IV, aminopeptidase M and angiotensin converting enzymePeptides, 1991
- β-Endorphin's modulation of lymphocyte proliferation is dose, donor, and time dependentBrain, Behavior, and Immunity, 1990
- Increased synthesis and production of prostaglandin E2 by monocytes from drug addicts with AIDSAIDS, 1989
- Opioid-mediated suppression of interferon-gamma production by cultured peripheral blood mononuclear cells.Journal of Clinical Investigation, 1987
- The differential effect with time of neuropeptides on the proliferative responses of murine Peyer's patch and splenic lymphocytesBrain, Behavior, and Immunity, 1987
- Intraneuronal Substance P Contributes to the Severity of Experimental ArthritisScience, 1984
- Substance P recognition by a subset of human T lymphocytes.Journal of Clinical Investigation, 1984
- Observation of the Effect of Substance P on Human T and B Lymphocyte ProliferationImmunological Communications, 1984